Skip to main content
OpenTrials

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,918 public trials 501 recruiting studies
Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Completed

Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)

NCT03158220

Conditions
Cervical Cancer, Communicable Diseases, Condylomata Acuminata, +36 more
Locations
  • Universitatsklinik fuer Frauenheilkunde und Geburtshilfe ( Site 0002) Graz, Austria
  • Klin. Abtlg. fuer Gynaekologie und Geburtshilfe ( Site 0001) Vienna, Austria
  • Universitair Ziekenhuis Antwerpen ( Site 0007) Edegem, Belgium
  • Universitair Ziekenhuis Gent ( Site 0006) Ghent, Belgium
View all 24 locations
View Trial Details
Completed

Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc

NCT00289731

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
Locations
  • GSK Investigational Site Wilrijk, Belgium
  • GSK Investigational Site Hradec Králové, Czechia
  • GSK Investigational Site Finsterwalde, Brandenburg, Germany
  • GSK Investigational Site Dresden, Saxony, Germany
View Trial Details
Completed

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females

NCT01462357

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
Locations
  • GSK Investigational Site Dax, France
  • GSK Investigational Site Draguignan, France
  • GSK Investigational Site Essey-lès-Nancy, France
  • GSK Investigational Site Le Havre, France
View all 21 locations
View Trial Details
Completed

Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix) Administered in Healthy Adolescents

NCT00534638

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • GSK Investigational Site Kotka, Finland
  • GSK Investigational Site Kuopio, Finland
  • GSK Investigational Site Lahti, Finland
  • GSK Investigational Site Rauma, Finland
View Trial Details
Completed

Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma

NCT01352117

Conditions
DNA Virus Infections, HIV-1 Infection, Herpesviridae Infections, +9 more
Locations
  • Instituto de Pesquisa Clinica Evandro Chagas (12101) Rio de Janeiro, Brazil
  • Walter Reed Project - Kenya Med. Research Institute Kericho CRS (12501) Kericho, Kenya
  • College of Med. JHU CRS (30301) Blantyre, Malawi
  • University of North Carolina Lilongwe CRS (12001) Lilongwe, Malawi
View Trial Details

Related conditions